MA
GSK icon

MONECO Advisors’s GSK GSK Stock Holding History

MONECO Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Sell
60,767
-3,702
-6% -$196K 0.19% 113
2026
Q1 		$3.56M Sell
64,469
-757
-1% -$41K 0.28% 78
2025
Q4 		$3.2M Buy
65,226
+54,913
+532% +$2.56M 0.25% 82
2025
Q3 		$445K Sell
10,313
-12
-0.1% -$469 0.04% 323
2025
Q2 		$396K Buy
10,325
+275
+3% +$10.5K 0.04% 336
2025
Q1 		$389K Sell
10,050
-572
-5% -$20.9K 0.04% 322
2024
Q4 		$359K Sell
10,622
-1,696
-14% -$61.1K 0.04% 338
2024
Q3 		$504K Buy
12,318
+744
+6% +$30.4K 0.06% 256
2024
Q2 		$446K Sell
11,574
-611
-5% -$25.7K 0.07% 253
2024
Q1 		$522K Sell
12,185
-248
-2% -$10.2K 0.08% 232
2023
Q4 		$461K Buy
12,433
+346
+3% +$12.4K 0.09% 224
2023
Q3 		$438K Buy
12,087
+3,444
+40% +$122K 0.12% 201
2023
Q2 		$308K Buy
8,643
+314
+4% +$11.3K 0.08% 250
2023
Q1 		$296K Buy
8,329
+1,835
+28% +$64.2K 0.09% 242
2022
Q4 		$228K Buy
+6,494
New +$216K 0.08% 232

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

MONECO Advisors's GSK Position: Q2 2026 in Review

MONECO Advisors reduced its GSK (GSK) stake by 5.7% in Q2 2026, selling an estimated $196K and leaving 60,767 shares worth $3.19M. The position accounts for 0.19% of the portfolio, ranked #113.

MONECO Advisors first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.56M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • MONECO Advisors held 60,767 shares of GSK worth $3.19M as of Q2 2026.
  • MONECO Advisors sold 3,702 GSK shares in Q2 2026, an estimated $196K.
  • GSK made up 0.19% of MONECO Advisors's portfolio in Q2 2026, its #113 holding.
  • MONECO Advisors first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • MONECO Advisors's GSK position peaked at $3.56M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.